Skip to main content

Hedgie: This biotech stock is going to zero

The hedge fund manager who has already made a killing betting against biotech company MannKind now says the stock will soon be worthless.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.